Axena Health, Inc.

AUBURNDALE, MA · Founded 2023 · Medtech · Private

Leva Pelvic Health System, a non-invasive medical device for women's pelvic health conditions

Claim this profile

Follows are private to you and power your alerts

Updated · axenahealth.com

Sector
Medtech
Headquarters
AUBURNDALE, MA
Founded
2023
Latest Form D
$15M, Apr 2026
Total capital
$41.8M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$41.8M
2 Form D · last Apr 2026
6 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
2
5 pending · first 2024
Rank in peer group#425 of 1112

Capital timeline

2023202420252026FEDERAL ↑EQUITY ↓Cumulative $41.8M1st Form D$26.8M2nd Form D$15M
2023202420252026FEDERAL ↑EQUITY ↓Cumulative $41.8M1st Form D$26.8M2nd Form D$15M

Latest events

  • Private capital raisedForm D · SEC · 2nd filing$15M
  • Private capital raisedForm D · SEC · 1st filing$26.8M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#425 · top 38%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Bret ChristensenDirectorNamed in SEC Form D filings
  • Donna ParrDirectorNamed in SEC Form D filings
  • Eileen MausExecutive Officer, DirectorNamed in SEC Form D filings
  • Jim O'ConnorExecutive OfficerNamed in SEC Form D filings
  • Jonathan DeanDirectorNamed in SEC Form D filings
  • Ric CoteDirectorNamed in SEC Form D filings
Show all 10 people
  • Samantha PulliamExecutive Officer, DirectorNamed in SEC Form D filings
  • Shacey PetrovicDirectorNamed in SEC Form D filings
  • Vincent RicciExecutive OfficerNamed in SEC Form D filings
  • Zina Affas BesseDirectorNamed in SEC Form D filings

What it has protected

USPTO · 2 granted of 7
  • PendingDevices, Systems, And Methods For Treating Urinary And Fecal IncontinenceUSPTOApplication 19400175
  • GrantedSystem And Method For Kegel TrainingUSPTOUS 12,311,228
  • PendingDevices, Systems, And Methods For Training Pelvic Floor MusclesUSPTOApplication 18904240
Show all 7 patent records
  • Devices, Systems, And Methods For Treating Urinary And Fecal IncontinenceMar 19, 2026 · Application 19400175Pending
  • System And Method For Kegel TrainingMay 27, 2025 · US 12,311,228Granted
  • Devices, Systems, And Methods For Training Pelvic Floor MusclesJan 30, 2025 · Application 18904240Pending
  • Treatment Of Urinary IncontinenceDec 26, 2024 · Application 18829813Pending
  • Devices, Systems, And Methods For Training Pelvic Floor MusclesNov 12, 2024 · US 12,138,019Granted
  • Devices, Systems, And Methods For Treating A Pelvic Floor DisorderApplication 63551357Pending
  • Devices, Systems, And Methods For Treating A Pelvic Floor DisorderApplication PCTUS2025015070Pending

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .